Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.83
-0.04 (-0.51%)
Feb 21, 2025, 4:00 PM EST - Market closed
Amneal Pharmaceuticals Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$10.00
Upside
+27.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $11 | Buy | Maintains | $9 → $11 | +40.49% | Nov 11, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $10 → $12 | Strong Buy | Maintains | $10 → $12 | +53.26% | Oct 2, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $9 | Sell → Hold | Upgrades | $9 | +14.94% | Sep 6, 2024 |
| Barclays | Barclays | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +27.71% | Aug 13, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $9 → $10 | Strong Buy | Maintains | $9 → $10 | +27.71% | Aug 12, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $6.25 → $8 | Strong Buy | Maintains | $6.25 → $8 | +2.17% | May 6, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $7 → $9 | Strong Buy | Reiterates | $7 → $9 | +14.94% | May 6, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +2.17% | Mar 21, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $5.5 → $6.25 | Strong Buy | Maintains | $5.5 → $6.25 | -20.18% | Mar 4, 2024 |
| Barclays | Barclays | Buy Maintains $6 → $8 | Buy | Maintains | $6 → $8 | +2.17% | Jan 29, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $6 → $7 | Strong Buy | Maintains | $6 → $7 | -10.60% | Nov 8, 2023 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | -23.37% | Sep 6, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $3 → $5 | Buy | Maintains | $3 → $5 | -36.14% | Aug 7, 2023 |
| Truist Securities | Truist Securities | Strong Buy Maintains $4 → $6 | Strong Buy | Maintains | $4 → $6 | -23.37% | Aug 7, 2023 |
| Barclays | Barclays | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | -36.14% | Aug 7, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $5 → $3 | Buy | Maintains | $5 → $3 | -61.69% | May 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.